Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Hongwei Lv, Guishuai Lv, Cian Chen, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 110-127.e5
Open Access | Times Cited: 198

Showing 26-50 of 198 citing articles:

Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
Nian Liu, Mingjie Yan, Qian Tao, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 9, pp. e007146-e007146
Open Access | Times Cited: 23
Cancer cell-intrinsic PD-1: Its role in malignant progression and immunotherapy
Muhua Chen, Lei Bie, Ying Jieer
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115514-115514
Open Access | Times Cited: 23
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer
Yu Jiang, Yawen Wang, Guofeng Chen, et al.
Cell Metabolism (2024) Vol. 36, Iss. 8, pp. 1806-1822.e11
Open Access | Times Cited: 15
Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion
Linlin Yan, Mingming Wu, Tianyu Wang, et al.
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1270-1285
Closed Access | Times Cited: 12
SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells
Mu‐Jie Lu, Jonathan Busquets, Valeria Impedovo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 808-821.e6
Closed Access | Times Cited: 12
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 12
Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer
Qingyun Zhu, Qiuzi Dai, Lei Zhao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
The hidden messengers: cancer associated fibroblasts—derived exosomal miRNAs as key regulators of cancer malignancy
Zixuan Gou, Jiannan Li, Jianming Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Jie Wu, Nian Liu, Jing Chen, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity
Yongfu Xiong, Yiming Weng, Shan Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Tumor Microenvironment and Cancer Metastasis
Yulong Li, Han Wu
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Advances in NAD-Lowering Agents for Cancer Treatment
Moustafa Ghanem, Fiammetta Monacelli, Alessio Nencioni
Nutrients (2021) Vol. 13, Iss. 5, pp. 1665-1665
Open Access | Times Cited: 51
Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
Yu Yuan, Abdalla Adam, Chen Zhao, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 663-663
Open Access | Times Cited: 50
Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing
Marı́a N. Navarro, Manuel M. Gómez de las Heras, Marı́a Mittelbrunn
British Journal of Pharmacology (2021) Vol. 179, Iss. 9, pp. 1839-1856
Open Access | Times Cited: 44
Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma
Peng Ding, Anbang He, Shiming He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 3, pp. 995-1007
Open Access | Times Cited: 28
The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
Sebastian Stępień, Paweł Olczyk, Joanna Gola, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1118-1118
Open Access | Times Cited: 22
Transcriptional control of pancreatic cancer immunosuppression by metabolic enzyme CD73 in a tumor-autonomous and -autocrine manner
Tianyu Tang, Xing Huang, Minghao Lu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 21
Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery
He Tang, Lin Wang, Tianyu Wang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115607-115607
Closed Access | Times Cited: 21
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 20
Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection
Graham A. Heieis, Thiago A. Patente, Luís Almeida, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes
Yougang Cui, Qihang Yuan, Junhong Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Truncated PD1 Engineered Gas‐Producing Extracellular Vesicles for Ultrasound Imaging and Subsequent Degradation of PDL1 in Tumor Cells
Siyan Zhang, Yuan Liang, Panpan Ji, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 7
Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin
Alina M. Perevalova, L. F. Gulyaeva, Vladimir O. Pustylnyak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2153-2153
Open Access | Times Cited: 7

Scroll to top